Item 4 — Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended and supplemented as follows: Cancellation of Convertible Notes and Common Stock On January 9, 2025, the Bankruptcy Court entered its order confirming the Reorganization Plan. On January 17, 2025 (the "Effective Date"), the Reorganization Plan became effective and the Issuer emerged from chapter 11 bankruptcy. The Shares were cancelled, released, and extinguished on the Effective Date. From and after the Effective Date, Reorganized ICD (as defined in the Reorganization Plan) intends to operate as a private company and expects to de-register its existing equity securities, and terminate its reporting obligations under the Securities Exchange Act of 1934, as amended. The common stock of the Reorganized ICD authorized to be issued and outstanding on or after the Effective Date (the "New Common Stock") is not expected to be listed on any national securities exchange. Pursuant to the Reorganization Plan, and in reliance on the exemption from registration requirements of the Securities Act of 1933, as amended, provided by Section 1145 of the Bankruptcy Code, 100% of the Notes were cancelled and the holders of the Notes, including the Reporting Persons, received their pro rata share of (i) 100% of the New Common Stock, subject to dilution on account of any equity issued pursuant to the Management Incentive Plan (as defined in the Reorganization Plan), and (ii) solely $7.5 million, on account of the Additional Notes (as defined in the Reorganization Plan), plus the amount of accrued and unpaid interest on the Additional Notes, in principal amount of loans issued under Reorganized ICD's Exit Term Loan Facility (as defined in the Reorganization Plan). In particular, the Reporting Persons received approximately 50.1% of the shares of the New Common Stock in exchange for the cancellation of their Notes.